Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry · 2026-09 · 20 (3-4) · 276-289
DOI: 10.1134/s1990750826600780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, online erschienen am 18.11.2026. Verfasst von S. K. Miroshnichenko und 7 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Miroshnichenko, S. K., Sen’kova, A. V., Savin, I. A., Demirel, R., Almieva, O. S., Kupryushkin, M. S., Maslov, M. A., & Zenkova, M. A. (2026). Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 20(3-4), 276-289. https://doi.org/10.1134/s1990750826600780
Vancouver
Miroshnichenko SK, Sen’kova AV, Savin IA, Demirel R, Almieva OS, Kupryushkin MS, et al. Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 2026;20(3-4):276-289. doi:10.1134/s1990750826600780
BibTeX
@article{Miroshnichenko2026,
author = {Miroshnichenko, S. K. and Sen’kova, A. V. and Savin, I. A. and Demirel, R. and Almieva, O. S. and Kupryushkin, M. S. and Maslov, M. A. and Zenkova, M. A.},
title = {Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts},
journal = {Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry},
year = {2026},
volume = {20},
number = {3-4},
pages = {276--289},
doi = {10.1134/s1990750826600780}
}
EUVIMED